跳至主要内容
临床试验/NL-OMON42933
NL-OMON42933已完成不适用

Pilot study: Biomarkers for the diagnosis of severe neutrophil inflammatory asthma. - Biomarkers for severe neutrophil inflammatory asthma

Rijnstate Ziekenhuis0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • All patients included in this study suffer from severe asthma. When a diagnosis of asthma is confirmed and comorbidities have been addressed, severe asthma is defined as asthma which requires treatment with high dose inhaled corticosteroids (ICS) plus a second controller (and/or systemic CS) to prevent it from becoming *uncontrolled* or which remains *uncontrolled* despite this therapy.

排除标准

  • -People suffering from other (chronic, pulmonary or autoimmune) diseases than asthma
  • -People suffering from an upper or lower respiratory infection within four weeks prior to investigation
  • -People having an immunodeficiency
  • -People taking antibiotics (macrolide trial included) or probiotics, four weeks prior to investigation
  • -People taking oral corticosteroids
  • -People who smoke.

研究者

发起方
Rijnstate Ziekenhuis

相似试验